Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML. by Hasle, H, Abrahamsson, J, Arola, M, Karow, A, O'Marcaigh, A, Reinhardt, D, Webb, D, van Wering, E, Zeller, B, Zwaan, C, Vyas, P

Natural history of GATA-1 mutations in Down syndrome. by Ahmed, M, Sternberg, A, Hall, G, Thomas, A, Smith, O, O'Marcaigh, A, Wynn, R, Stevens, R, Stewart, B, Gibson, B, Roberts, I, Vyas, P

Natural history of GATA1 mutations in Down syndrome. by Ahmed, M, Sternberg, A, Hall, G, Thomas, A, Smith, O, O'Marcaigh, A, Wynn, R, Stevens, R, Addison, M, King, D, Stewart, B, Gibson, B, Roberts, I, Vyas, P

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. by Norton, A, Fisher, C, Liu, H, Wen, Q, Mundschau, G, Fuster, J, Hasle, H, Zeller, B, Webb, D, O'Marcaigh, A, Sorrell, A, Hilden, J, Gamis, A, Crispino, J, Vyas, P